Last checked at Today 12:17
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News3
AZN Share
Chat
AZN Share
Trades16,401
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,050.00
Bid:
12,038.00
Ask:
12,040.00
Change:
-106.00 (-0.87%)
Spread:
2.00 (0.017%)
Open:
12,092.00
High:
12,178.00
Low:
12,010.00
Prev. Close:
12,156.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.London pre-open: Positive start expected after record close on Wall Street
Tue, 03rd Mar 2015 07:50
UK stocks are expected to open with modest gains on Tuesday following a decent performance on Wall Street the night before, as investors watch corporate earnings on a quiet day for economic data.City sources predict the FTSE 100 will open 10 points higher than Monday's close of 6,940.64.Both the Dow Jones and S&P 500 closed at record highs the previous session, while the Nasdaq Composite finished above 5,000 for the first time in 15 years.Following a barrage of economic indicators released on Monday, Tuesday's session is looking pretty quiet, with German retail sales and the Eurozone producer price index being the only major releases.Stocks to watchCost saving initiatives helped Barclays grow its annual pre-tax profit by 12% last year, but the bank set aside £1.25bn for provisions to cover litigation costs related to ongoing probes into misconduct and rigging foreign exchange rates.Commodities trader and mining group Glencore managed to meet City expectations with a 2% decline in operating profits in 2014 as strong earnings growth in its marketing division was outweighed by falling prices dragging on its industrial business. It also said that in response other volatile backdrop for commodities markets, the capital expenditure budget for 2015 has been cut to $6.5bn-6.8bn from previous guidance of $7.9bn.Housebuilder Taylor Wimpey has doubled its dividend payment after unveiling impressive profits growth in 2014 and enjoying better-than-expected trading in the new year. On revenue up 17% to £2.69bn, the FTSE 100 group drove a 68% increase in profit before tax and exceptional items to £450.1m and proposed a near tripling in the final dividend to 1.32p per share.AstraZeneca has completed its acquisition of the rights to Activis' branded respiritory business in the US and Canada. AstraZeneca has paid Actives $600m of initial consideration as well as an extra $100m for a number of contractual consents and approvals.
More News
Today 11:50
Angle shares up on assay development deal with AstraZenaca
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.
Read moreToday 07:50
LONDON BRIEFING: InterContinental Hotels makes first-quarter progress
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.
Read more2 May 2024 10:04
AstraZeneca notes positive trial results for Calquence treatment
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.
Read more2 May 2024 07:45
AstraZeneca reports positive results from blood cancer drug trial
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.
Read more29 Apr 2024 22:52
J&J, Bristol Myers lose challenges to US drug price negotiation program
April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.
Read more29 Apr 2024 10:02
LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read more29 Apr 2024 09:13
AstraZeneca makes progress with Truqap and Enhertu cancer treatments
(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.
Read more29 Apr 2024 07:50
LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid
(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.
Read more29 Apr 2024 07:24
AstraZeneca makes progress with two breast cancer treatments
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Read more26 Apr 2024 09:33
LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:
Read more25 Apr 2024 16:57
LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge
(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.
Read more25 Apr 2024 15:14
London close: Stocks finish mixed as US GDP growth slows
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.
Read more25 Apr 2024 11:50
LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American
(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.
Read more25 Apr 2024 10:33